Metagenomi, Inc. (MGX)
(Delayed Data from NSDQ)
$2.04 USD
-0.05 (-2.39%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $2.03 -0.01 (-0.49%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum C VGM
Metagenomi (MGX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$15.17 | $25.00 | $6.00 | 625.84% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Metagenomi comes to $15.17. The forecasts range from a low of $6.00 to a high of $25.00. The average price target represents an increase of 625.84% from the last closing price of $2.09.
Analyst Price Targets (6 )
Broker Rating
Metagenomi currently has an average brokerage recommendation (ABR) of 1.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.29 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, six are Strong Buy, representing 85.71% of all recommendations. A month ago, Strong Buy represented 85.71%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.29 | 1.29 | 1.29 | 1.29 | 1.29 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/21/2024 | H.C. Wainwright & Co. | Mitchell S Kapoor | Strong Buy | Strong Buy |
8/19/2024 | Chardan Capital Markets | Geulah Livshits | Strong Buy | Strong Buy |
8/15/2024 | BMO Capital Markets | Kostas Biliouris | Strong Buy | Strong Buy |
8/14/2024 | Cowen & Co. | Joseph Thome | Strong Buy | Strong Buy |
8/14/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
3/5/2024 | Wells Fargo Securities | Yanan Zhu | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.29 |
ABR (Last week) | 1.29 |
# of Recs in ABR | 7 |
Average Target Price | $15.17 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 89 of 253 |
Current Quarter EPS Est: | -0.70 |
MGX FAQs
Metagenomi, Inc. (MGX) currently has an average brokerage recommendation (ABR) of 1.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for Metagenomi, Inc. (MGX) is $15.17. The current on short-term price targets is based on 4 reports.
The forecasts for Metagenomi, Inc. (MGX) range from a low of $6 to a high of $25. The average price target represents a increase of $643.63 from the last closing price of $2.04.
The current UPSIDE for Metagenomi, Inc. (MGX) is 643.63%
Based on short-term price targets offered by six analysts, the average price target for Metagenomi comes to $15.17. The forecasts range from a low of $6.00 to a high of $25.00. The average price target represents an increase of 625.84% from the last closing price of $2.09.